Showing 1 - 9 results of 9 for search 'Daniel J O’Shannessy', query time: 0.04s Refine Results
  1. 1
    Folate Receptor Alpha, Mesothelin and Megakaryocyte Potentiating Factor as Potential Serum Markers of Chronic Kidney Disease

    Folate Receptor Alpha, Mesothelin and Megakaryocyte Potentiating Factor as Potential Serum Markers of Chronic Kidney Disease by Elizabeth B. Somers, Daniel J. O’Shannessy

    Published 2014-05-01
    Get full text
    Article
  2. 2
    Folate Receptor Alpha, Mesothelin and Megakaryocyte Potentiating Factor as Potential Serum Markers of Chronic Kidney Disease

    Folate Receptor Alpha, Mesothelin and Megakaryocyte Potentiating Factor as Potential Serum Markers of Chronic Kidney Disease by Elizabeth B. Somers, Daniel J. O'Shannessy

    Published 2014-01-01
    Get full text
    Article
  3. 3
    Isolation of Circulating Tumor Cells from Multiple Epithelial Cancers with ApoStream for Detecting (or Monitoring) the Expression of Folate Receptor Alpha

    Isolation of Circulating Tumor Cells from Multiple Epithelial Cancers with ApoStream for Detecting (or Monitoring) the Expression of Folate Receptor Alpha by Daniel J. O'Shannessy, Darren W. Davis, Kenna Anderes, Elizabeth B. Somers

    Published 2016-01-01
    Get full text
    Article
  4. 4
    Isolation of Circulating Tumor Cells from Multiple Epithelial Cancers with ApoStream for Detecting (or Monitoring) the Expression of Folate Receptor Alpha

    Isolation of Circulating Tumor Cells from Multiple Epithelial Cancers with ApoStream for Detecting (or Monitoring) the Expression of Folate Receptor Alpha by Daniel J. O'Shannessy, Darren W. Davis, Kenna Anderes, Elizabeth B. Somers

    Published 2016-02-01
    Get full text
    Article
  5. 5
    Co-development of diagnostic vectors to support targeted therapies and theranostics: Essential tools in Personalized Cancer Therapy.

    Co-development of diagnostic vectors to support targeted therapies and theranostics: Essential tools in Personalized Cancer Therapy. by Nicholas C Nicolaides, Daniel J. O'shannessy, Earl eAlbone, Luigi eGrasso

    Published 2014-06-01
    Get full text
    Article
  6. 6
    Identification of circulating tumor cells captured by the FDA-cleared Parsortix® PC1 system from the peripheral blood of metastatic breast cancer patients using immunofluorescence and cytopathological evaluations

    Identification of circulating tumor cells captured by the FDA-cleared Parsortix® PC1 system from the peripheral blood of metastatic breast cancer patients using immunofluorescence... by Mariacristina Ciccioli, Kyukwang Kim, Negar Khazan , Joseph D Khoury, Martin J Cooke, M Craig Miller, Daniel J O’Shannessy, Anne-Sophie Pailhes-Jimenez, Richard G Moore

    Published 2024-08-01
    Get full text
    Article
  7. 7
    Specific loss of adipocyte CD248 improves metabolic health via reduced white adipose tissue hypoxia, fibrosis and inflammationResearch in context

    Specific loss of adipocyte CD248 improves metabolic health via reduced white adipose tissue hypoxia, fibrosis and inflammationResearch in context by Paul Petrus, Tara L. Fernandez, Michelle M. Kwon, Jenny L. Huang, Victor Lei, Nooshin Seyed Safikhan, Subashini Karunakaran, Daniel J. O'Shannessy, Xiaowei Zheng, Sergiu-Bogdan Catrina, Earl Albone, Jukka Laine, Kirsi Virtanen, Susanne M. Clee, Timothy J. Kieffer, Christophe Noll, André C. Carpentier, James D. Johnson, Mikael Rydén, Edward M. Conway

    Published 2019-06-01
    Get full text
    Article
  8. 8
    Folate receptor-α (FOLR1) expression and function in triple negative tumors.

    Folate receptor-α (FOLR1) expression and function in triple negative tumors. by Brian M Necela, Jennifer A Crozier, Cathy A Andorfer, Laura Lewis-Tuffin, Jennifer M Kachergus, Xochiquetzal J Geiger, Krishna R Kalari, Daniel J Serie, Zhifu Sun, Alvaro Moreno-Aspitia, Daniel J O'Shannessy, Julia D Maltzman, Ann E McCullough, Barbara A Pockaj, Heather E Cunliffe, Karla V Ballman, E Aubrey Thompson, Edith A Perez

    Published 2015-01-01
    Get full text
    Article
  9. 9
    Correction: Folate receptor-α (FOLR1) expression and function in triple negative tumors.

    Correction: Folate receptor-α (FOLR1) expression and function in triple negative tumors. by Brian M Necela, Jennifer A Crozier, Cathy A Andorfer, Laura Lewis-Tuffin, Jennifer M Kachergus, Xochiquetzal J Geiger, Krishna R Kalari, Daniel J Serie, Zhifu Sun, Alvaro Moreno-Aspitia, Daniel J O'Shannessy, Julia D Maltzman, Ann E McCullough, Barbara A Pockaj, Heather E Cunliffe, Karla V Ballman, E Aubrey Thompson, Edith A Perez

    Published 2015-01-01
    Get full text
    Article

Search Tools: